Avalo Therapeutics Inc (AVTX)
Healthcare
Biotechnology
18.10 $
-1.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Avalo Therapeutics Inc (AVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -6.8 | -2.8 | -6.2 | -16 | -12 | -15 | -9.5 | -11 | -16 | -14 | -18 | -60 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | |
| 0.9 | 1.0 | 0.8 | 0.6 | 0.5 | 1.8 | 2.9 | 3.2 | 2.7 | 3.2 | 4.5 | 3.6 | 14 | |
| 0.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.2 | -3.6 | 0.1 | -1.3 | -1.3 | -1.5 | -0.6 | 1.2 | 3.6 | -1.1 | 0.2 | -1.1 | 1.6 | |
| 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.2 | – | -0.2 | 0.4 | 0.4 | – | – | – | -71 | -13 | 2.4 | 26 | -56 | |
| – | – | 0.1 | – | – | – | – | – | 0.0 | – | 0.0 | – | – | |
| -6.0 | – | – | – | – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | |
| 0.6 | 11 | 0.0 | 109 | -0.5 | 0.0 | 68 | 0.0 | -0.5 | 14 | 0.7 | 1.4 | 16 | |
| -10 | 3.9 | -2.8 | 103 | -17 | -12 | 53 | -9.5 | -83 | -15 | -11 | 9.2 | -100 | |
| -11 | -6.8 | -2.9 | -6.2 | -16 | -12 | -15 | -9.5 | -11 | -16 | -14 | -18 | -60 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.